PET Scan Role in Gastroesophageal Tumor Staging
Positron Emission Tomography (PET) scans, typically using the tracer fluorodeoxyglucose (FDG), are valuable tools in cancer staging. They work by detecting areas of higher metabolic activity, which often correspond to cancerous tissue.
In the context of preoperative staging for gastroesophageal tumors, PET scans are primarily used to:
- Detect lymph node status: PET is highly effective at identifying metastatic involvement in lymph nodes. Cancerous lymph nodes often exhibit increased glucose uptake (FDG uptake), making them visible on the scan. This is crucial for determining the extent of disease spread.
- Identify distant metastatic disease: PET scans can reveal cancer that has spread to distant organs, such as the liver, lungs, or bones.
While imaging like CT or MRI is often used to assess local tumor invasion and anatomical detail, PET's strength lies in detecting metabolically active microscopic or macroscopic disease, particularly in lymph nodes and distant sites. Therefore, assessing lymph node status is a key application of PET in staging these tumors.
Important Questions from Oesophagus
Which of the following statements are correct regarding Barrett's oesophagus?
1. It is a metaplastic change.
2. It is a risk factor for development of adenocarcinoma.
3. Ingestion of NSAIDs is the aetiological factor for its development.
4. Endoscopic mucosal resection is an effective treatment.
Select the answer using the code given below.
- Positron Emission Tomography (PET) used in Preoperative staging of Gastro Oesophageal tumours is to detect
- What is true about the management of a corrosive injury of oesophagus?
An air fluid level with dilated oesophagus and "bird beak" appearance in a barium swallow is diagnostic of:
- Gastric conduit after oesophageal resection is based upon:
